What does APOTHEEK JANS do?

APOTHEEK JANS is a pharmacy in Riemst. Public Limited, started on 27 June 1986, 1 establishment.

What is the address of APOTHEEK JANS?

The registered office of APOTHEEK JANS is located at Visésteenweg 211, 3770 Riemst.

Is APOTHEEK JANS still active?

Yes. According to the CBE (29 October 2026) APOTHEEK JANS is active, legal situation “Normale toestand”, started on 27 June 1986.

Is APOTHEEK JANS registered on Peppol?

Yes, APOTHEEK JANS is registered on the Peppol network with ID 0208:0429230839.

What is the enterprise number of APOTHEEK JANS?

The enterprise number of APOTHEEK JANS is BE0429230839.

When was APOTHEEK JANS founded?

APOTHEEK JANS was founded on 27 June 1986.

Who are the directors of APOTHEEK JANS?

According to the 2025 annual accounts, the directors of APOTHEEK JANS are: Léon Jans, Mees Management Apotheek BV BV.

Is APOTHEEK JANS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 June 1986; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK JANS make in 2025?

APOTHEEK JANS recorded a loss after taxes of € 27,787 in financial year 2025.

What is the revenue of APOTHEEK JANS?

As a small company, APOTHEEK JANS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 83,468.

How much does an employee at APOTHEEK JANS earn?

The average wage cost per full-time employee at APOTHEEK JANS was € 53,400 in 2022: staff costs of € 69,396 for 1.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK JANS have?

According to the 2025 annual accounts, APOTHEEK JANS has 0.9 full-time equivalents (FTE).

APOTHEEK JANS (Public Limited) - Riemst - BE0429230839

Dossier APOTHEEK JANS, printed on 29 October 2026 from databakkes.be/en/0429230839/apotheek-jans. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 44 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK JANS from Riemst, company number BE0429230839, closed financial year 2025 with a result of € -27,787 after tax. For that financial year APOTHEEK JANS recorded a gross margin of € 83,468 and equity of € 148,615. Compared with financial year 2024, the result moved from € 22,740 to € -27,787. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 21, 2026.

What it is worth Healthy

€ 148,615

▼ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -27,787

▼ still € 22,740 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 38,981

▼ 59% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -55,897.

People and assets in 2025

Full-time equivalents

0.9

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 44,252

▲ 8% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 549

▼ 55% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 645,821

▲ € 506,796 vs 2024

€ 80,529 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 343,095

▲ 26% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 5,378

▼ 4% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 55,577 Gross margin 2022: € 55,577 First fiscal year in the series	€ 28,788 Gross margin 2023: € 28,788 ▼ 48% vs 2022 (€ 55,577) Unfavourable step	€ 81,178 Gross margin 2024: € 81,178 ▲ 182% vs 2023 (€ 28,788) Favourable step	€ 83,468 Gross margin 2025: € 83,468 ▲ 3% vs 2024 (€ 81,178) Favourable step	▲ 3%
Profit after taxes	€ -35,443 Profit after taxes 2022: € -35,443 First fiscal year in the series	€ -38,733 Profit after taxes 2023: € -38,733 ▼ € 3,290 vs 2022 (€ -35,443) Unfavourable step	€ 22,740 Profit after taxes 2024: € 22,740 ▲ € 61,473 vs 2023 (€ -38,733) Favourable step	€ -27,787 Profit after taxes 2025: € -27,787 ▼ € 50,527 vs 2024 (€ 22,740) Unfavourable step	▼ € 50,527
Equity	€ 192,395 Equity 2022: € 192,395 First fiscal year in the series	€ 153,662 Equity 2023: € 153,662 ▼ 20% vs 2022 (€ 192,395) Unfavourable step	€ 176,402 Equity 2024: € 176,402 ▲ 15% vs 2023 (€ 153,662) Favourable step	€ 148,615 Equity 2025: € 148,615 ▼ 16% vs 2024 (€ 176,402) Unfavourable step	▼ 16%
Total debts	€ 535,307 Total debts 2022: € 535,307 First fiscal year in the series	€ 424,270 Total debts 2023: € 424,270 ▼ 21% vs 2022 (€ 535,307) Favourable step	€ 425,372 Total debts 2024: € 425,372 Unchanged (€ 424,270) Unfavourable step	€ 1,027,849 Total debts 2025: € 1,027,849 ▲ 142% vs 2024 (€ 425,372) Unfavourable step	▲ 142%
Cash	€ 250,587 Cash 2022: € 250,587 First fiscal year in the series	€ 69,311 Cash 2023: € 69,311 ▼ 72% vs 2022 (€ 250,587) Unfavourable step	€ 95,666 Cash 2024: € 95,666 ▲ 38% vs 2023 (€ 69,311) Favourable step	€ 38,981 Cash 2025: € 38,981 ▼ 59% vs 2024 (€ 95,666) Unfavourable step	▼ 59%
Land & buildings	€ 206,400 Land & buildings 2022: € 206,400 First fiscal year in the series	€ 197,828 Land & buildings 2023: € 197,828 ▼ 4% vs 2022 (€ 206,400) Unchanged	€ 189,256 Land & buildings 2024: € 189,256 ▼ 4% vs 2023 (€ 197,828) Unchanged	€ 850,109 Land & buildings 2025: € 850,109 ▲ € 660,853 vs 2024 (€ 189,256) Unchanged	▲ € 660,853
Retained profit	€ -12,117 Retained profit 2022: € -12,117 First fiscal year in the series	€ -50,850 Retained profit 2023: € -50,850 ▼ € 38,733 vs 2022 (€ -12,117) Unfavourable step	€ -28,110 Retained profit 2024: € -28,110 ▲ € 22,740 vs 2023 (€ -50,850) Favourable step	€ -55,897 Retained profit 2025: € -55,897 ▼ € 27,787 vs 2024 (€ -28,110) Unfavourable step	▼ € 27,787
Bank debt	€ 236,945 Bank debt 2022: € 236,945 First fiscal year in the series	€ 188,750 Bank debt 2023: € 188,750 ▼ 20% vs 2022 (€ 236,945) Favourable step	€ 139,025 Bank debt 2024: € 139,025 ▼ 26% vs 2023 (€ 188,750) Favourable step	€ 645,821 Bank debt 2025: € 645,821 ▲ € 506,796 vs 2024 (€ 139,025) Unfavourable step	▲ € 506,796
Balance sheet total	€ 730,677 Balance sheet total 2022: € 730,677 First fiscal year in the series	€ 580,907 Balance sheet total 2023: € 580,907 ▼ 20% vs 2022 (€ 730,677) Unchanged	€ 604,749 Balance sheet total 2024: € 604,749 ▲ 4% vs 2023 (€ 580,907) Unchanged	€ 1,179,439 Balance sheet total 2025: € 1,179,439 ▲ 95% vs 2024 (€ 604,749) Unchanged	▲ 95%
Employees (FTE)	1.3 Employees (FTE) 2022: 1.3 First fiscal year in the series	0.9 Employees (FTE) 2023: 0.9 ▼ 0.4 vs 2022 (1.3) Unchanged	0.9 Employees (FTE) 2024: 0.9 Unchanged (0.9) Unchanged	0.9 Employees (FTE) 2025: 0.9 Unchanged (0.9) Unchanged

Key figures of APOTHEEK JANS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK JANS?

What happened at APOTHEEK JANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 21, 2026 New annual accounts for financial year 2025: loss of € 27,787 (▼ € 50,527 vs 2024). Source: NBB ↗
2021 Léon Jans became a director. NBB
2021 Mees Management Apotheek BV BV became a director. NBB
Aug 8, 1986 New establishment in Riemst. KBO
Jun 27, 1986 Start of the company according to the CBE. KBO

In short

From € 35,443 loss in 2022 to € 27,787 loss in 2025.

Paid € 3 in corporate taxes since 2022.

Best year ever: 2024, with € 22,740 profit.

On average € 42,800 of value added per employee in 2022.

Original PDFs at the National Bank ↗

Management

MEES MANAGEMENT APOTHEEK 100%

The stake of MEES MANAGEMENT APOTHEEK comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK JANS

Behind APOTHEEK JANS are Léon Jans and Mees Management Apotheek BV BV. The shares are held by MEES MANAGEMENT APOTHEEK (100%).

Directors

According to the 2025 annual accounts

Léon Jans

Director

since 2021

Mees Management Apotheek BV BV

Managing director · represented by Joris Mees

Also active at: APOTHEEK MEES HASSELT, APOTHEEK MEES HAACHT CENTRUM, APOTHEEK VAN GORP, APOTHEEK MEES ZONHOVEN, APOTHEEK MEES SCHULEN, APOTHEEK MEES HERK-DE-STAD, APOTHEEK MEES SINT-TRUIDEN, APOTHEEK T'KINDT +14 more

since 2021

Shareholders

MEES MANAGEMENT APOTHEEK

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Visésteenweg 211

3770 Riemst

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

MB Pharmaceutics

€ 61,193 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0429.230.839

VAT number

BE 0429.230.839

Registered office

Visésteenweg 211, 3770 Riemst

Names & denominations

APOTHEEK JANS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

27 June 1986

Peppol

Active · Active since 23 Oct 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK JANS

Warning lights

Financials

What happened to APOTHEEK JANS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions